ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against renal injury and inflammation in mice with diabetic kidney disease

Yang, Yi-Qi; Tan, Hai-Bo; Zhang, Xiao-Yu; Zhang, Yu-Zhen; Lin, Quan-You; Huang, Min-Yi; Lin, Zi-Yang; Mo, Jia-Zhi; Zhang, Yue; Lan, Tian; Bei, Wei-Jian; Guo, Jiao*广东药学院
Journal of Ethnopharmacology2022-6-28DOI: 10.1016/j.jep.2022.115165
14被引24阅读
引用收藏
分享

摘要

Ethnopharmacological relevance: Fufang Zhenzhu Tiaozhi capsule (FTZ) is a patented preparation of Chinese herbal medicine that has been used to treat hyperlipidemia, nonalcoholic fatty liver disease, atherosclerosis, and other glucolipid metabolic diseases (GLMDs) in the clinic for almost 10 years. However, how FTZ reduces albuminuria and attenuates diabetic kidney disease (DKD) progression is unknown. @@@ Aim of the study: To clarify the effects of FTZ on DKD mice model and to explore the underlying mechanisms. @@@ Materials and methods: We used streptozotocin (STZ) (40 mg/kg/d, i.p. for 5 days, consecutively) combined with a high-fat diet (HFD) to induce a DKD mouse model, followed by FTZ (1, 2 g/kg/d, i.g.) treatment for 12 weeks. Losartan (30 mg/kg/d, i.g.) was used as a positive control. Measurements of 24 h proteinuria, serum creatinine (SCr), fasting blood glucose (FBG), total cholesterol (TC), triglyceride (TG), and low density lipoprotein cholesterol (LDL-C) levels and expression levels of fibronectin (FN), collagen IV, inflammatory cytokines, inflammatory cells, interleukin-17A (IL-17A) and the nuclear transcription factor-kappa B (NF-kappa B) signaling pathway in the kidney were examined. @@@ Results: FTZ effectively decreased 24 h proteinuria, Scr, FBG, TC, TG, and LDL-C levels, inhibited mesangial cell expansion, reduced FN and collagen IV accumulation, and F4/80+ macrophage cell infiltration and Ly-6G+ neutrophil infiltration in glomerulus and tubulointerstitium. Furthermore, IL-17A production and the NF-kappa B signaling pathway were also downregulated after the administration of FTZ. @@@ Conclusion: FTZ might attenuate DKD progression, and inhibited kidney inflammation and fibrosis by inhibiting the expression of ROR gamma T and IL-17A in vivo, offering novel insights for the clinical application of FTZ.

学科与关键词

关键词
Diabetic kidney diseaseChinese medicineInflammation
相关
加载中…
  • Traditional Chinese Medicine Fufang-Zhenzhu-Tiaozhi capsule prevents renal injury in diabetic minipigs with coronary heart disease
    Song, Lixia; Wang, Ke; Yin, Jianying; Yang, Yiqi; Li, Bo; Zhang, Dongxing; Wang, Hong; Wang, Weixuan; Zhan, Wenjing; Guo, Caijuan; Gu, Zhanhui; Wang, Lexun; Zeng, Zhihuan; Bei, Weijian*; Rong, Xianglu; Guo, Jiao*Chinese Medicine, 2022, 17(1): 102.被引 2
  • FTZ polysaccharides ameliorate kidney injury in diabetic mice by regulating gut-kidney axis
    Lan, Tian*; Tang, Tang; Li, Ying; Duan, Yingling; Yuan, Qin; Liu, Wen; Ren, Yuqing; Li, Ning; Liu, Xuenan; Zhang, Yu; Li, Xinglong; Jin, Guifang; Wang, Shengpeng; Guo, Jiao*PHYTOMEDICINE, 2023, 118: 154935.被引 2
  • Fufang Zhenzhu Tiaozhi capsule ameliorates hyperuricemic nephropathy by inhibition of PI3K/AKT/NF-?B pathway
    Li, Ming -Hui; Guan, Jin; Chen, Zhe; Mo, Ju-Xian; Wu, Kai-Reng; Hu, Xu-Guang; Lan, Tian*; Guo, JiaoJournal of Ethnopharmacology, 2022, 298: 115644.被引 8
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Ethnopharmacology
发表日期
2022-06-28
卷期
第 292 卷
页码
115165
DOI
10.1016/j.jep.2022.115165
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Key Project of National Natural Science Foundation of China [81830113]; National key R&D plan "Research on modernization of traditional Chinese medicine" [2018YFC1704200]; Major basic and applied basic research projects of Guangdong Province of China [2019B030302005]; Guangdong Medical Science and Technology Research Fund [B2020023]; Basic and applied basic research project of Guangzhou

作者

  • Y

    Yang, Yi-Qi (第一作者)

    guangdong pharmaceut univ

  • T

    Tan, Hai-Bo

    guangdong pharmaceut univ

查看全部 12 位作者收起作者
  • Z

    Zhang, Xiao-Yu

    guangdong pharmaceut univ

  • Z

    Zhang, Yu-Zhen

  • L

    Lin, Quan-You

    guangdong pharmaceut univ

  • H

    Huang, Min-Yi

    guangdong pharmaceut univ

  • L

    Lin, Zi-Yang

    guangdong pharmaceut univ

  • M

    Mo, Jia-Zhi

    guangdong pharmaceut univ

  • Z

    Zhang, Yue

  • L

    Lan, Tian

    guangdong pharmaceut univ

  • B

    Bei, Wei-Jian

    guangdong pharmaceut univ

  • G

    Guo, Jiao (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417